BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 38004502)

  • 1. Gene and Cellular Therapies for Leukodystrophies.
    Aerts-Kaya F; van Til NP
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for leukodystrophies.
    Biffi A; Aubourg P; Cartier N
    Hum Mol Genet; 2011 Apr; 20(R1):R42-53. PubMed ID: 21459776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advancements in the Diagnosis and Treatment of Leukodystrophies.
    Bradbury AM; Ream MA
    Semin Pediatr Neurol; 2021 Apr; 37():100876. PubMed ID: 33892849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
    Ashrafi MR; Amanat M; Garshasbi M; Kameli R; Nilipour Y; Heidari M; Rezaei Z; Tavasoli AR
    Expert Rev Neurother; 2020 Jan; 20(1):65-84. PubMed ID: 31829048
    [No Abstract]   [Full Text] [Related]  

  • 5. Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy.
    Bergner CG; van der Meer F; Winkler A; Wrzos C; Türkmen M; Valizada E; Fitzner D; Hametner S; Hartmann C; Pfeifenbring S; Stoltenburg-Didinger G; Brück W; Nessler S; Stadelmann C
    Glia; 2019 Jun; 67(6):1196-1209. PubMed ID: 30980503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
    Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
    Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for neurodegenerative disorders in children: dreams and realities.
    Boespflug-Tanguy O; Sevin C; Piguet F
    Arch Pediatr; 2023 Nov; 30(8S1):8S32-8S40. PubMed ID: 38043981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and pitfalls of cell therapy in metabolic leukodystrophies.
    Miranda CO; Brites P; Mendes Sousa M; Teixeira CA
    Cell Transplant; 2013; 22(2):189-204. PubMed ID: 23006656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in leukodystrophies.
    Eichler F; Van Haren K
    Pediatr Neurol; 2007 Oct; 37(4):235-44. PubMed ID: 17903666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.
    Page KM; Stenger EO; Connelly JA; Shyr D; West T; Wood S; Case L; Kester M; Shim S; Hammond L; Hammond M; Webb C; Biffi A; Bambach B; Fatemi A; Kurtzberg J
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):e363-e374. PubMed ID: 31499213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recognition of patients with leukodystrophies.
    Modesti NB; Evans SH; Jaffe N; Vanderver A; Gavazzi F
    Curr Probl Pediatr Adolesc Health Care; 2022 Dec; 52(12):101311. PubMed ID: 36470810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency.
    Silver JN; Elder M; Conlon T; Cruz P; Wright AJ; Srivastava A; Flotte TR
    Hum Gene Ther; 2011 Aug; 22(8):935-49. PubMed ID: 21142972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inherited leukodystrophies: a clinical overview.
    Aicardi J
    J Inherit Metab Dis; 1993; 16(4):733-43. PubMed ID: 7692130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
    Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Veres G; Schmidt M; Kutschera I; Vidaud M; Abel U; Dal-Cortivo L; Caccavelli L; Mahlaoui N; Kiermer V; Mittelstaedt D; Bellesme C; Lahlou N; Lefrère F; Blanche S; Audit M; Payen E; Leboulch P; l'Homme B; Bougnères P; Von Kalle C; Fischer A; Cavazzana-Calvo M; Aubourg P
    Science; 2009 Nov; 326(5954):818-23. PubMed ID: 19892975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies.
    von Jonquieres G; Rae CD; Housley GD
    Front Cell Neurosci; 2021; 15():661857. PubMed ID: 34239416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
    Aubourg P
    Endocr Dev; 2016; 30():141-6. PubMed ID: 26684481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scope and Burden of Non-Standard of Care Hematopoietic Stem Cell Transplantation in Pediatric Leukodystrophy Patients.
    Bonkowsky JL; Wilkes J; Shyr DC
    J Child Neurol; 2018 Dec; 33(14):882-887. PubMed ID: 30261790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment.
    Berger J; Moser HW; Forss-Petter S
    Curr Opin Neurol; 2001 Jun; 14(3):305-12. PubMed ID: 11371752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].
    Cartier N; Hacein-Bey-Abina S; Von Kalle C; Bougnères P; Fischer A; Cavazzana-Calvo M; Aubourg P
    Bull Acad Natl Med; 2010 Feb; 194(2):255-64; discussion 264-8. PubMed ID: 21166117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients.
    Müller vom Hagen J; Karle KN; Schüle R; Krägeloh-Mann I; Schöls L
    Eur J Neurol; 2014 Jul; 21(7):983-8. PubMed ID: 24698313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.